Olga Granaturova is the Co-Founder & President of PriveBio. Till recently Olga was Chief Operating Officer, Co-Founder and Board Member of Parthenon Therapeutics, a precision oncology company reprogramming the tumor microenvironment. She is a veteran pharma/biotech leader with over 25 years of diverse multidisciplinary experience in R&D, commercial launches, business development, strategy, fundraising, licensing, and M&A transactions (Pfizer, BMS, Merck). Olga has led teams that have successfully delivered 20 clinical drug candidates, 3 drug launches, and multi-year/multi-million-dollar deals (sell and buy sides). Olga is also the President and Co-Founder of Brighter Ventures, a 501(c)(3) non profit organization advancing women-led entrepreneurship, and serves on a board of a pediatric oncology non profit organization.